Advances in Diabetes Research: New Insights into Insulin Secretion, Sensitivity, and Glycemic Control

Strategic Insights -

A recent wave of research has provided valuable insights into the intricacies of diabetes, with studies from France, the United States, and Italy shedding light on the mechanisms of insulin secretion, sensitivity, and glycemic control. The findings of these studies have significant implications for the treatment and management of type 1 and type 2 diabetes.

Key Takeaways:

  • Insulin secretion appears to be the major determinant of diabetic control in overt type 2 diabetic patients treated with metformin alone or with a two-drug therapy combining metformin and glyburide, according to a study published in the European Journal of Clinical Investigation (Monnier et al., 2006).
  • Administering lispro insulin with meals improves glycemic control, increases circulating leptin, and suppresses ghrelin, compared with regular/NPH insulin in female patients with type 1 diabetes, as reported in the Journal of Clinical Endocrinology and Metabolism (Griffen et al., 2006).
  • Postabsorptive albumin synthesis and its response to insulin were normal in type 2 diabetic patients, but fibrinogen synthesis was increased, according to a study from Italy published in Diabetes Care (Tessari et al., 2006).
  • More closely mimicking normal insulin, leptin, and ghrelin responses to meals with fast-acting insulin may have implications for body weight regulation in type 1 diabetes, as suggested by Griffen and colleagues.
  • Hyperfibrinogenemia and increased leucine rate of appearance were associated with worse metabolic control in the type 2 diabetic patients, whereas neither the increased fibrinogen ASR nor the normal albumin production was affected, as shown by Tessari et al.

Statistics:

  • In group I (metformin alone) of study 1, mean HbA1c values were greater (8.4%) in patients with HOMA2%B (European Journal of Clinical Investigation, Monnier et al., 2006).
  • Leptin increased more on the Lispro (2.7[+ or -]0.7 vs. 0.7[+ or -]0.5 ng/mL, p=0.02) after lunch with Lispro, compared with regular/NPH insulin in female patients with type 1 diabetes (Journal of Clinical Endocrinology and Metabolism, Griffen et al., 2006).
  • Fibrinogen synthesis was increased (24.9[+ or -]2.1%/day) in type 2 diabetic patients, according to the study published in Diabetes Care (Tessari et al., 2006).
  • Albumin FSR (11.2[+ or -]0.9%/day) and albumin ASR (15.4[+ or -]1.2 g/day) were not different from control values in type 2 diabetic patients (Diabetes Care, Tessari et al., 2006).

Sources:

  • Monnier, L., et al. (2006). Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes. European Journal of Clinical Investigation, 36(4), 231-235.
  • Griffen, S. C., et al. (2006). Administration of lispro insulin with meals improves glycemic control, increases circulating leptin, and suppresses ghrelin, compared with regular/NPH insulin in female patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism, 91(2), 485-491.
  • Tessari, P., et al. (2006). Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. Diabetes Care, 29(2), 323-328.